Free Trial

United Therapeutics (UTHR) SEC Filings & 10K Form

United Therapeutics logo
$359.58 -0.58 (-0.16%)
(As of 12/20/2024 05:31 PM ET)

Recent United Therapeutics SEC Filings

DateFilerForm TypeView
12/18/2024
4:51 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
3:31 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:38 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:32 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:44 AM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:37 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:04 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:32 AM
Olian Judy D. (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:17 PM
Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
4:07 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:33 PM
Giltner Richard (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:45 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:23 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2024
5:32 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
5:34 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:13 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:19 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
12:03 PM
STATE STREET CORP (Filed by)
United Therapeutics (Subject)
Form SC 13G
10/15/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:19 AM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:20 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:34 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:35 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:18 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:24 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Amazon coin set to soar 25X – starting December 16th? (Ad)

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

08/20/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:16 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
4:17 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
9:54 AM
United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/31/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:31 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:33 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
MAXWELL LINDA (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:31 PM
MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:30 PM
MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
6:30 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:08 PM
Thompson Tommy G (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
3:36 PM
Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:37 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
AI breakthrough about to upend industry (Ad)

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

06/18/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:36 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:33 PM
Olian Judy D. (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:06 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:UTHR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners